CD1A and psoriasis: Significantly, psoriasis pathogenesis may also depend on CD1a; when imiquimod-treated CD1a-transgenic mice, which are a model of psoriasiform inflammation, were treated with anti-CD1a, their amount of skin inflammation dropped significantly97.